Critics warn RFK Jr. report linking acetaminophen to autism could revive mother-blaming
Forthcoming report, widely reported to link prenatal Tylenol use to autism, draws criticism from experts and advocates who say evidence is weak and risks stigmatizing pregnant women

Robert F. Kennedy Jr.'s much-anticipated report on autism, due this month, is drawing sharp criticism from medical experts, advocates and commentators who say a widely reported claim that acetaminophen use in pregnancy is linked to autism risks reviving an old pattern of blaming mothers rather than addressing complex scientific questions.
If, as has been widely reported, the report will argue that prenatal use of acetaminophen — the active ingredient in Tylenol — is associated with an increased risk of autism, critics say that framing will repeat a decades-old tendency to hold maternal behavior responsible for neurodevelopmental conditions.
Columnists and parent advocates point to historical examples in which mothers were blamed for children's developmental differences, most notably the "refrigerator mother" theory of the 1950s, and say reviving similar narratives would be harmful. Bethany Mandel, writing in an opinion column, argued that singling out a common, over-the-counter medication could intensify guilt and fear among parents and expectant mothers.
The scientific evidence on acetaminophen and neurodevelopment is mixed, and researchers caution that an observed association does not establish causation. A 2021 meta-analysis published by investigators affiliated with Harvard's School of Public Health reported a possible association between prenatal acetaminophen exposure and higher risks of autism and ADHD. But public health specialists and clinicians note that meta-analyses compiling observational studies are subject to confounding factors and cannot prove a direct causal link.
Large-scale, well-controlled studies have not provided consistent evidence that acetaminophen causes autism, and leading medical organizations generally advise that acetaminophen, when used as directed, remains the preferred analgesic and antipyretic during pregnancy. Some obstetric and pediatric experts caution that discouraging pregnant women from using acetaminophen without clear alternatives could lead to untreated fever or pain, which itself can carry risks in pregnancy.
Researchers have highlighted several potential confounders that may help explain observed associations. Maternal fever during early pregnancy has been linked in some studies to increased risk of neurodevelopmental conditions, and women who take acetaminophen are more likely to have had an infection or inflammatory condition. Parental age, particularly the father's age at conception, has been associated with autism risk in other studies. Diagnostic changes over recent decades — including the consolidation of Asperger's syndrome into the autism spectrum — also complicate comparisons over time and contribute to rising diagnosis rates.
Critics of the reported RFK Jr. thesis say the social consequences of headline-grabbing claims must be considered alongside scientific uncertainty. In an opinion piece, Mandel argued that reviving narratives that attribute complex developmental outcomes to single maternal behaviors could exacerbate public anxiety and contribute to decisions by some younger women to delay or avoid childbearing. She cited polling that has found many women in younger generations expressing reluctance to have children, in part because of perceived pressures and risks associated with modern parenting.
Public health experts and autism researchers called for careful communication of scientific findings and for research conducted with methodological rigor. They emphasized the need to distinguish between preliminary associations warranting further study and conclusions that should drive changes in clinical guidance.
Advocates for families affected by autism said they want more investment in research, therapies, educational supports and social services rather than renewed focus on assigning blame. Support groups and clinicians routinely stress that autism is a complex condition with genetic, neurological and environmental dimensions and that no single factor has been identified as a sole cause.
The debate over acetaminophen and neurodevelopment has practical implications for clinical guidance. Acetaminophen is widely recommended by clinicians because alternative common pain relievers, such as nonsteroidal anti-inflammatory drugs, are generally avoided in pregnancy. Any shift in messaging from public officials or health authorities could affect prescribing patterns and patient behavior.
As the report's release approaches, researchers and clinicians urged clear, evidence-based messaging that helps pregnant people make informed decisions in consultation with their health providers. They also called for further well-designed studies to disentangle the complex web of potential influences on neurodevelopment and for policymakers to focus on improving services and supports for children and families living with autism.
Advocates said the conversation should center on delivering reliable science and practical support rather than reviving stigmatizing narratives. They argued that public health communications that emphasize uncertainty where it exists, and that avoid assigning blame, are essential to protecting both maternal health and child development.